scholarly article | Q13442814 |
P819 | ADS bibcode | 1991PNAS...88.6234D |
P356 | DOI | 10.1073/PNAS.88.14.6234 |
P8608 | Fatcat ID | release_oqzusgwk6jgghpmmpqloyn3zzi |
P932 | PMC publication ID | 52057 |
P698 | PubMed publication ID | 2068104 |
P5875 | ResearchGate publication ID | 21088134 |
P2093 | author name string | Sonenberg N | |
Roy S | |||
Rosen CA | |||
Reid L | |||
Barnett R | |||
Sumner-Smith M | |||
Delling U | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Total chemical synthesis of a 77-nucleotide-long RNA sequence having methionine-acceptance activity | Q24651950 | ||
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein | Q24656004 | ||
Structural and functional characterization of human immunodeficiency virus tat protein | Q24656163 | ||
α-Helix–double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine model | Q59087308 | ||
A region of basic amino-acid cluster in HIV-1 Tat protein is essential for trans-acting activity and nucleolar localization | Q64378953 | ||
Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate | Q64380630 | ||
Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev | Q68505951 | ||
A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation | Q68583028 | ||
A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation | Q69355887 | ||
The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain | Q69366191 | ||
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
Identification and characterization of a HeLa nuclear protein that specifically binds to the trans-activation-response (TAR) element of human immunodeficiency virus | Q33575002 | ||
Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface | Q33643113 | ||
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat | Q33662926 | ||
Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor | Q33681763 | ||
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro | Q33900660 | ||
The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
A second post-transcriptional trans-activator gene required for HTLV-III replication | Q34162178 | ||
Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region | Q34284937 | ||
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro | Q34303073 | ||
Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA | Q34311433 | ||
Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events | Q34344850 | ||
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat | Q34563887 | ||
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat | Q34564367 | ||
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis | Q35226113 | ||
5'-3' exonucleases in phosphorothioate-based oligonucleotide-directed mutagenesis | Q35943171 | ||
Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence. | Q36802812 | ||
The art gene product of human immunodeficiency virus is required for replication | Q36827056 | ||
trans activation of human immunodeficiency virus type 1 is sequence specific for both the single-stranded bulge and loop of the trans-acting-responsive hairpin: a quantitative analysis. | Q36832567 | ||
Regulation of expression of human immunodeficiency virus | Q37783139 | ||
Tat and Rev: positive regulators of HIV gene expression | Q37947555 | ||
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat | Q38346354 | ||
Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization | Q40108559 | ||
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat | Q40129795 | ||
A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator | Q40650101 | ||
Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids | Q41208182 | ||
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure | Q41234955 | ||
HIV-1 tat trans-activation requires the loop sequence within tar. | Q44349676 | ||
Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition | Q44540333 | ||
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication | Q44579665 | ||
Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements | Q45040167 | ||
Fragments of the HIV-1 Tat protein specifically bind TAR RNA. | Q45148606 | ||
Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein | Q45830211 | ||
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
Tat protein from human immunodeficiency virus forms a metal-linked dimer | Q45841752 | ||
Tat trans-activates the human immunodeficiency virus through a nascent RNA target | Q45847022 | ||
Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat | Q46674379 | ||
Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function | Q58611466 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6234-6238 | |
P577 | publication date | 1991-07-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA | |
P478 | volume | 88 |
Q41077313 | A plant viral coat protein RNA binding consensus sequence contains a crucial arginine |
Q63351469 | Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity |
Q40393681 | Bidirectional effectors of a group I intron ribozyme |
Q34378982 | CD39 is an ecto-(Ca2+,Mg2+)-apyrase |
Q68188961 | Conformation of the TAR RNA-Arginine Complex by NMR Spectroscopy |
Q36697484 | Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure |
Q36798014 | Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein |
Q38318473 | Design and synthesis of RNA miniduplexes via a synthetic linker approach. 2. Generation of covalently closed, double-stranded cyclic HIV-1 TAR RNA analogs with high Tat-binding affinity |
Q36115020 | Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins |
Q36486560 | Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein |
Q40047125 | Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. |
Q33930854 | Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation |
Q38617624 | Functional roles of HIV-1 Tat protein in the nucleus. |
Q47627653 | Furin cleavage of the HIV-1 Tat protein |
Q39619066 | Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia |
Q36233715 | HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes |
Q45782813 | Host virus interactions and the molecular regulation of HIV-1: role in the pathogenesis of HIV-associated nephropathy |
Q74358809 | Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells |
Q40815938 | Inhibition of human immunodeficiency virus type 1 tat-trans-activation-responsive region interaction by an antiviral quinolone derivative |
Q37273867 | Insight into the mechanisms of aminoglycoside derivatives interaction with HIV-1 entry steps and viral gene transcription |
Q28140555 | Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style |
Q40396291 | NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus |
Q35881363 | Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. |
Q35222971 | Peptide models of the tat—Tar protein‐RNA interaction |
Q71144400 | Protein orientation in the Tat-TAR complex determined by psoralen photocross-linking |
Q34752187 | Quantitative analysis of Tat peptide binding to import carriers reveals unconventional nuclear transport properties |
Q33192810 | Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat) |
Q24606166 | Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen |
Q34961590 | Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNA |
Q73853265 | Specific recognition of HIV-1 TAR RNA by a D-Tat peptide |
Q33997066 | Specificity of RSG-1.2 peptide binding to RRE-IIB RNA element of HIV-1 over Rev peptide is mainly enthalpic in origin |
Q44139962 | Structural requirements for conserved Arg52 residue for interaction of the human immunodeficiency virus type 1 trans-activation responsive element with trans-activator of transcription protein (49-57). Capillary electrophoresis mobility shift assay. |
Q45158264 | Structure-activity relationships of aminoglycoside-arginine conjugates that bind HIV-1 RNAs as determined by fluorescence and NMR spectroscopy |
Q36642378 | TAR RNA binding properties and relative transactivation activities of human immunodeficiency virus type 1 and 2 Tat proteins. |
Q34755910 | Tat-neutralizing antibodies in vaccinated macaques |
Q36635773 | The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. |
Q40656567 | The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis |
Q36798758 | The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism |
Q24613668 | The translation initiation factor eIF-4B contains an RNA-binding region that is distinct and independent from its ribonucleoprotein consensus sequence |
Q24681560 | Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication |
Q40027334 | Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells |
Search more.